Valitor
PrivateLast Round
Series B
Oct 5, 2022
Total Funding Raised
$28M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Valitor is a biotechnology company that develops long-acting therapeutic proteins using a proprietary multivalent biopolymer technology platform to improve treatment outcomes in ophthalmology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Valitor Comparables
Compare Valitor with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Serina Therapeutics Inc | 81% | |
| Day One Biopharmaceuticals | 76% | |
| Sanofi | 73% | |
Valitor Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 5, 2022 | ||||
| VC Round | Dec 22, 2021 |
Key People
Founding team and executive leadership
Valitor Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Berkeley Catalyst Fund | Series B, Series A |
| First Spark Ventures | Series B |
| Morningside Group | Series B |
| ExSight Ventures | Series B |
| Pandect Bioventures | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 3, 2026
Presenting new preclinical data at the ARVO Annual Meeting on May 3, 2026.
- Apr 13, 2026
CEO to present at the 25th Annual Needham Virtual Healthcare Conference.
Valitor Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Valitor's valuation, stock price, and market status.